Simultaneous quantification of infliximab and adalimumab in human plasma by liquid chromatography-tandem mass spectrometry using ready-to-use kit and comparison with two ELISA methods - Archive ouverte HAL
Article Dans Une Revue Fundamental & Clinical Pharmacology Année : 2022

Simultaneous quantification of infliximab and adalimumab in human plasma by liquid chromatography-tandem mass spectrometry using ready-to-use kit and comparison with two ELISA methods

Résumé

Meeting Abstract PS-035

Domaines

Sciences du Vivant [q-bio]

Laurent Jonchère  : Connectez-vous pour contacter le contributeur

https://hal.science/hal-03789389

Soumis le : mardi 27 septembre 2022-13:34:36

Dernière modification le : jeudi 17 octobre 2024-10:52:03

Fichier non déposé

Dates et versions

hal-03789389 , version 1 (27-09-2022)

Identifiants

  • HAL Id : hal-03789389 , version 1

Citer

C. Tron, F. Lemaitre, P. Bros, C. Goulvestre, B. Franck, et al.. Simultaneous quantification of infliximab and adalimumab in human plasma by liquid chromatography-tandem mass spectrometry using ready-to-use kit and comparison with two ELISA methods. Fundamental & Clinical Pharmacology, 2022, 36, pp.110-110. ⟨hal-03789389⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-RENNES1 UNIV-ANGERS IRSET UR1-UFR-SVE UNIV-RENNES IRSET-11 UR1-BIO-SA
19 Consultations
0 Téléchargements

Partager

More